not directed at .......Platinumstandard.......but confirming with what you were saying.I see it, the increased use of TAVR that is the pivotal point here - and the reasons why it is likely to gain traction and to build the world wide demand for the procedure.
When it is the go to procedure for valve replacement, then as we all hope, Admedus will have the go to product.
News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-475
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
